Skip to main content
Equibles

DCVC Opportunity Fund II GP, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1668343 PALO ALTO, CA
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,500,687
+$2,370,685 QoQ
Shares Held
3,951,141
0.0% QoQ
Ownership
0.738%
of shares outstanding
% of Portfolio
84.30%
of 13F equity value
Holder Rank
#18
of 344 holders
Holding Since
Dec 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DCVC Opportunity Fund II GP, LLC holds $14,500,687 across 1 Biotechnology name. RXRX ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RXRX
Recursion Pharmaceuticals, Inc.
This page 		3,951,141 $14,500,687

All Filings in RXRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,500,687 3,951,141
2026-03-31 $12,130,002 3,951,141
2025-12-31 $16,160,166 3,951,141
2025-09-30 $19,281,568 3,951,141
2025-06-30 $19,992,773 3,951,141
2025-03-31 $20,901,535 3,951,141
2024-12-31 $26,709,713 3,951,141
2024-09-30 $26,038,019 3,951,141
2024-06-30 $29,633,557 3,951,141
2024-03-31 $39,392,875 3,951,141
2023-12-31 $38,958,250 3,951,141
2022-09-30 $42,040,140 3,951,141
2022-06-30 $32,162,287 3,951,141
2022-03-31 $28,290,169 3,951,141
2021-12-31 $67,683,045 3,951,141